Table 1.
Demographics | Used CBD (N=428) N (%) |
Not Used CBD (N=176) N (%) |
P-value |
---|---|---|---|
Age (y) | |||
18–34 | 123 (28.7) | 45 (25.6) | <.001* |
35–54 | 202 (47.2) | 59 (33.5) | |
55–64 years old | 60 (14) | 43 (24.4) | |
65 years and older | 43 (10) | 29 (16.5) | |
Gender | |||
Female | 272 (63.6) | 121 (68.8) | .14 |
Male | 139 (32.5) | 53 (30.1) | |
Prefer not to say | 17 (4.0) | 2 (1.1) | |
Ethnicity | |||
White | 357 (83.4) | 151 (85.8) | .83 |
Asian/Pacific Islander | 8 (1.8) | 3 (1.7) | |
African American | 17 (4.0) | 9 (5.1) | |
Hispanic or Latino | 18 (4.2) | 5 (2.8) | |
Native American | 5 (1.2) | 0 (0) | |
Other | 16 (3.7) | 3 (1.7) | |
Not disclosed | 7 (1.6) | 5 (2.8) | |
Geographya | |||
Other country | 64 (15.0) | 21 (11.9) | .01* |
Midwest | 68 (15.9) | 35 (19.9) | |
Northeast | 95 (22.2) | 52 (29.5) | |
South | 104 (24.3) | 47 (26.7) | |
West | 97 (22.7) | 21 (11.9) | |
Education | |||
High school | 96 (22.4) | 33 (18.8) | .87 |
Associate degree | 85 (19.9) | 38 (21.6) | |
Bachelor’s degree | 184 (43.0) | 77 (43.8) | |
Doctorate degree | 45 (10.5) | 21 (11.9) | |
Not disclosed | 18 (4.2) | 7 (4) | |
Income | |||
<$30,000 | 102 (23.8) | 32 (18.2) | .29 |
$30,000–$54,999 | 79 (18.5) | 38 (21.6) | |
$55,000–$99,999 | 114 (26.6) | 56 (31.8) | |
≥100,000 | 78 (18.2) | 25 (14.2) | |
Rather not say | 55 (12.9) | 25 (14.2) | |
Type of arthritis | |||
Osteoarthritis | 204 (47.7) | 80 (45.5) | .99 |
Rheumatoid arthritis | 142 (33.2) | 55 (31.3) | |
Other autoimmune arthritis | 82 (19.1) | 32 (18.2) | |
Unsure/missing | 0 | 9 (5.1) | |
How did you hear about CBD?b | |||
Friends or family | 166 (38.8) | ||
Internet/social media | 151 (35.3) | ||
Medical personnel | 48 (11.2) | ||
Periodical/television | 9 (2.1) | ||
Unsure | 54 (12.6) | ||
Spoke to the doctor about your CBD use? | |||
No | 195 (45.6) | ||
Yes | 233 (54.4) | ||
Friends/family use CBD? | |||
No | 75 (17.5) | ||
Yes | 353 (82.5) |
Y years, $ US dollars, % percent, CBD cannabidiol
Statistical comparisons performed with Pearson chi-squared test between groups
*Significance determined as P<0.05
aGeographic regions based on US Census Divisions
bAll patients in the analysis answered “yes” for have you heard of CBD